0
0
34 words
0
Comments
A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.
You are the first to view
https://www.cnn.com/2022/11/17/health/tzield-teplizumab-diabetic-treatment/index.html
Create an account or login to join the discussion